170 related articles for article (PubMed ID: 21540377)
1. Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.
Zanger P; Kötter I; Raible A; Gelanew T; Schönian G; Kremsner PG
Am J Trop Med Hyg; 2011 May; 84(5):692-4. PubMed ID: 21540377
[TBL] [Abstract][Full Text] [Related]
2. Rhinophyma-Like Cutaneous Leishmaniasis due to
Kirchberger MC; Schliep S; Bogdan C
Am J Trop Med Hyg; 2019 Feb; 100(2):231-232. PubMed ID: 30774067
[No Abstract] [Full Text] [Related]
3. Molecular diagnosis and therapy for cutaneous leishmaniasis of a returned traveler from Mexico.
Tsai PH; Chen YT; Liau JY; Huang MH; Hsu HM; Yeong EK; Hung CC
J Microbiol Immunol Infect; 2021 Dec; 54(6):1154-1158. PubMed ID: 32741680
[TBL] [Abstract][Full Text] [Related]
4. [A multifocal form of cutaneous leishmaniasis caused by Leishmania infantum in an immunocompetent child treated with a short course of liposomal amphotericin B].
Taquin H; Chiaverini C; Marty P; Lacour JP
Ann Dermatol Venereol; 2016 Oct; 143(10):622-624. PubMed ID: 27292718
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Leishmania tropica in children: report of three imported cases successfully treated with liposomal amphotericin B.
Knöpfel N; Noguera-Morel L; Azorin D; Sanz F; Torrelo A; Hernández-Martín A
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e8-e10. PubMed ID: 28653351
[No Abstract] [Full Text] [Related]
6. [Liposomal amphotericin B treatment of cutaneous leishmaniasis caused by L. braziliensis: an imported case report].
Navarrete-Dechent C; Cevallos C; Jercic MI; Saldias-Fuentes C; González S; Labarca J
Rev Chilena Infectol; 2018; 35(5):612-616. PubMed ID: 30725012
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous leishmaniasis in a Japanese returnee from West Africa successfully treated with liposomal amphotericin B.
Ono M; Takahashi K; Taira K; Uezato H; Takamura S; Izaki S
J Dermatol; 2011 Nov; 38(11):1062-1065. PubMed ID: 21950705
[TBL] [Abstract][Full Text] [Related]
8. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient.
Mirzabeigi M; Farooq U; Baraniak S; Dowdy L; Ciancio G; Vincek V
J Cutan Pathol; 2006 Oct; 33(10):701-4. PubMed ID: 17026523
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.
del Rosal T; Artigao FB; Miguel MJ; de Lucas R; del Castillo F
J Trop Pediatr; 2010 Apr; 56(2):122-4. PubMed ID: 19656844
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of Disseminated Cutaneous Leishmaniasis With Liposomal Amphotericin B and Miltefosine in an Eight-year-old Girl.
Hamzavi SS; Sanaei Dashti A; Kadivar MR; Pouladfar G; Pourabbas B
Pediatr Infect Dis J; 2018 Mar; 37(3):275-277. PubMed ID: 29424815
[TBL] [Abstract][Full Text] [Related]
15. Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
Hervás JA; Martín-Santiago A; Hervás D; Rojo E; Mena A; Rocamora V; Dueñas J
Pediatr Infect Dis J; 2012 Jan; 31(1):97-100. PubMed ID: 21829140
[TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
[TBL] [Abstract][Full Text] [Related]
17. An Australian case of New World cutaneous leishmaniasis.
Konecny P; Stark DJ
Med J Aust; 2007 Mar; 186(6):315-7. PubMed ID: 17371215
[No Abstract] [Full Text] [Related]
18. Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B.
Roustan G; Jiménez JA; Gutiérrez-Solar B; Gallego JL; Alvar J; Patrón M
Br J Dermatol; 1998 Mar; 138(3):526-8. PubMed ID: 9580814
[TBL] [Abstract][Full Text] [Related]
19. Ocular Leishmaniasis Treated by Intralesional Amphotericin B.
Nikandish M; Goyonlo VM; Taheri AR; Kiafar B
Middle East Afr J Ophthalmol; 2016; 23(1):153-5. PubMed ID: 26957858
[TBL] [Abstract][Full Text] [Related]
20. Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis.
Kosaka A; Sakamoto N; Hikone M; Imai K; Ota M; Washino T; Maeda T; Iwabuchi S
Intern Med; 2020; 59(9):1227-1230. PubMed ID: 32378656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
